DC Circ. Says ViroPharma Can't Sue FDA Over Generics Ruling
By Steven Melendez ( March 21, 2012, 3:41 PM EDT) -- The D.C. Circuit on Wednesday affirmed a lower court's decision that ViroPharma Inc. lacked standing to challenge a U.S. Food and Drug Administration ruling on generic drugs that allegedly set a precedent affecting the pharmaceutical company's business....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.